21 May 2013
Keywords: Arimidex, Faslodex, Combination therapy, Breast cancer, AstraZeneca, SWO
Article | 02 August 2012
Postmenopausal women with the most common type of metastatic breast cancer now have a new treatment option that lengthens their ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 August 2012
1 August 2012
20 May 2013
© 2013 thepharmaletter.com